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SLUG Bug: Quality Improvement
With Orchestrated Testing Leads
to NICU CLABSI Reduction
Anthony J. Piazza, MD,a,b Beverly Brozanski, MD,c Lloyd Provost, MS,d Theresa R. Grover, MD,e John
Chuo, MD, MS,f,g Joan R. Smith, PhD, NNP-BC,h,i Teresa Mingrone, MSN, RN,c Susan Moran, DNP, NNPBC,e Lorna Morelli, ADN, RN, j Isabella Zaniletti, PhD, j Eugenia K. Pallotto, MD, MSCEk,l

OBJECTIVE: Reduce central line–associated bloodstream infection (CLABSI)

abstract

rates 15% over 12 months in children’s hospital NICUs. Use orchestrated
testing as an approach to identify important CLABSI prevention practices.
METHODS: Literature review, expert opinion, and benchmarking were used

to develop clinical practice recommendations for central line care. Four
existing CLABSI prevention strategies (tubing change technique, hub care
monitoring, central venous catheter access limitation, and central venous
catheter removal monitoring) were identified for study. We compared
the change in CLABSI rates from baseline throughout the study period in
17 participating centers. Using orchestrated testing, centers were then
placed into 1 of 8 test groups to identify which prevention practices had the
greatest impact on CLABSI reduction.
RESULTS: CLABSI rates decreased by 19.28% from 1.333 to 1.076 per 1000
line-days. Six of the 8 test groups and 14 of the 17 centers had decreased
infection rates; 16 of the 17 centers achieved >75% compliance with process
measures. Hub scrub compliance monitoring, when used in combination
with sterile tubing change, decreased CLABSI rates by 1.25 per 1000
line-days.
CONCLUSIONS: This multicenter improvement collaborative achieved a decrease

in CLABSI rates. Orchestrated testing identified infection prevention
practices that contribute to reductions in infection rates. Sterile tubing
change in combination with hub scrub compliance monitoring should be
considered in CLABSI reduction efforts.
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Health care–associated infections
(HAIs) are a burden to patients
and the health care system. It is
estimated that up to 50% of HAIs are
preventable.1,2 In 2002, however, HAIs
in US hospitals reportedly reached
∼1.7 million, with >33 000 HAIs
among infants in high-risk nurseries.3
Central line–associated bloodstream
infections (CLABSIs) have the highest
cost per HAI and contribute to
significant morbidities, mortality, and
length of stay in the adult, pediatric,

and neonatal populations.4–6 The
overall direct annual cost of US HAIs
ranges from $35.7 to $45 billion for
inpatient hospital services.7 Although
the actual cost of CLABSIs varies,
the attributable cost to care is up to
$69 000 per event.7–11
Despite the risks with their use,
central venous catheters (CVCs)
play an integral role in modern
health care.12 The need for CVCs is
particularly important in children’s
hospital NICUs for patients who
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have diagnoses associated with
impaired cardiorespiratory and
intestinal function.13 CVCs are
necessary for fluids, nutrition, and
medications. Although not CLABSIspecific, evidence is growing that
patients with a neonatal infection
are more likely to have long-term
neurodevelopmental impairment
and lower scores on motor and
psychosocial development indices.14
The processes to lower CLABSI rates
could therefore have a powerful
impact on NICU outcomes.
Centers participating in the
Children’s Hospitals Neonatal
Database (CHND), a data repository
developed for IIIc15 NICUs,
established the CHND Collaborative
Initiatives for Quality Improvement
(CIQI) in 2009 to lead quality
improvement (QI) projects in
children’s hospital NICUs. CHND
currently has 28 member tertiary
and quaternary NICUs.13 Clancy et
al16 as well as others17 have recently
described a need for this type of
formal structure for collaborative
QI projects. The purpose of the
SLUG Bug (Standardizing Line Care
Under Guideline Recommendations)
collaborative was to provide
potentially better practice
recommendations for neonatal
health care professionals in care
and maintenance of CVCs and to
prevent CLABSIs. The 12-month
baseline mean CLABSI rate for the
collaborative was 1.33 per 1000
line-days (center-specific rates
varied from 0.23 to 3.4), which is
below the rate of 1.55 per 1000
line-days reported by the National
Healthcare Safety Network’s Level
III NICUs in 2011.18 The SMART
(Specific, Measurable, Attainable,
Relevant, Timeframe) aim of SLUG
Bug was to decrease collaborative
baseline CLABSI rates by a clinically
meaningful target of 15% over 12
months. A second objective of this
project was to use orchestrated
testing (OT) to identify important
CLABSI prevention practices.

METHODS
SLUG Bug was developed and
implemented by a multidisciplinary
group of experts from 8 CHND
member hospitals. The management
team included representatives from
neonatal nursing, neonatal advanced
practice nursing, and neonatal
physicians, as well as statistical
and process improvement experts
familiar with QI and guideline
development methods. Inclusion
criteria for the project involved
CHND membership and agreement
to participate for the entire project
period. Each hospital had a Level
IIIc15 NICU designation, >40
admissions annually, >25 inpatient
beds, and >50% of admissions being
outborn.13 Seventeen CHND hospital
NICUs joined the QI collaborative and
were committed to further reducing
CLABSI rates.
A questionnaire was developed to
describe specific CLABSI prevention
policies. The 54-item survey was
distributed to 25 CHND member
NICUs with 24 responses. This
benchmarking survey, a systematic
literature review, and expert opinion
were the basis for the development of
a CLABSI reduction Clinical Practice
Recommendation for children’s
hospital NICUs. The Clinical Practice
Recommendation underwent a
systematic review process that used
the AGREE II instrument.19 The areas
outlined in the recommendation
include suggestions for hand
hygiene, central line insertion,
central line maintenance, root cause
analysis,20 and recommendations for
compliance monitoring (Table 1, see
Appendix).
After reviewing the Clinical Practice
Recommendation, each institution
was asked to define local CVC care
practices and identify process
improvement opportunities. The
evidence supporting hand hygiene,
central line insertion, dressing
changes, and root cause analysis
is well established.12,20,21 Other
areas of central line care (including

duration of hub care [HC] time,
tubing change [TC] techniques,
line entry, and removal plans) vary
widely in local hospital practice; this
variation was confirmed by hospital
survey. For this collaborative, OT was
used to determine if potential best
practices could be identified from
this variation.22,23 A 24–1 fractional
factorial design matrix22 of 8 distinct
factor/level combinations (test
groups) was developed by using 4
dichotomous factors: sterile versus
clean TC technique, HC compliance
monitoring versus not monitoring,
CVC line entry access limitation
versus no specific limitations, and
CVC line removal tracking versus no
tracking policy (Tables 2 and 3). Each
center selected the practices in 1 of 8
test groups to adopt and/or maintain.
Some had practices congruent to
the selected test group and did not
modify practice, whereas others
planned to implement changes.
No center discontinued CLABSI
prevention practices. Centers agreed
not to implement factors that were
not assigned to their group, and they
were discouraged from changing
additional practices for the study
period.
The Children’s Mercy Hospital
(Kansas City, MO) Pediatric
Institutional Review Board reviewed
this project and determined it did
not meet the definition of research
involving human subjects. Data
submitted and analyzed were unit
based and contained no patient
identifiers. Each participating site
adhered to their local institution
requirements to determine if
additional institutional review board
approval was needed.
Several key components of the IHI
breakthrough series collaborative
framework were used to facilitate
the project by incorporating sessions
directed at team learning and
sharing; providing a communication
structure that included monthly
webinars, an active listserv
forum, and access to an expert
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clinician panel; and assigning QI
advisors.24 Each site assembled
a multidisciplinary group of key
stakeholders that included physician,
nursing, and site leaders. On monthly
collaborative calls, teams shared
experiences and Plan-Do-Study-Act
cycles (focused on implementation
and monitoring of assigned factors)
to facilitate transparency as well as
learning across centers. Collaborative
huddles fostered open discussion
in smaller groups. The IHI Extranet,
a data system for QI collaboratives,
was used by the teams for reporting
measures, accessing a listserv for
project participants, and storing
project resource documents. It
also allowed teams to track and
graph data over time and monitor
improvement progress through
submission of progress reports and
IHI team assessment scores.25,26
The primary outcome measure
was CLABSI rates according to the
National Healthcare Safety Network’s
definition of CLABSI.27 Process
measures were defined and collected
by self-report or direct observation
(Table 4). For the groups assigned to
compliance monitoring, a minimum
of 10 observations per month from
a consistent observer were required
as described in the Clinical Practice
Recommendation, with an expected
target compliance of >75% and an
ideal target of ≥90%. Each local
team instituted tools and processes
for data collection and shared
information among sites to adapt
as needed. The balancing measure
was defined as unintended line
replacement.
Baseline CLABSI rates were
established on the basis of rates
at each site from January 2011 to
December 2011. The study period
(January 2012–December 2012)
focused on compliance monitoring,
data sharing, and ongoing local
Plan-Do-Study-Act cycles to achieve
targeted improvement goals. Centers
were expected to submit outcome

TABLE 1 Clinical Practice Recommendations for CLABSI Prevention
Recommendations
Hand hygiene

Staff and family

Central line insertion

Use of insertion
checklist
HC practice

Central line
maintenance

TC technique

Dressing change
technique

Daily line removal
assessment
Frequency of line
entry
Root cause analysis

Minimum Recommendations for Teams
Hand washing or use of hand sanitizer immediately
before and after patient contact
Dedicated teams; sterile barrier; site preparation scrub
and dry; sterile dressing
70% Alcohol prep or ChloraPrep as per NICU protocol
• Scrub time = 15 s minimum and up to 60 s
• Dry time = until dry
Sterile: minimum to include sterile gloves and mask with
use of sterile barrier under the CVC
- OR Clean: minimum to include clean gloves with sterile
gauze barriers under the CVC
Deﬁne frequency, site preparation, and dressing type per
speciﬁc NICU protocol. Dressing changes require
sterile technique. All individuals actively involved in
dressing change must wear mask and sterile gloves
• For Broviac; PICC (central or midline); subclavian,
jugular, or femoral central line
o Weekly and as-needed if dressing becomes wet,
soiled, or nonocclusive
• Hand hygiene
o Current dressing may be removed with clean
gloves with hand hygiene performed after
removal of gloves
• Site dressing
o Apply sterile dressing per manufacturer speciﬁcations
o Track date/time of dressing change, insertion, and
removal
• Site preparation
o <2 mo or corrected GA or weight as deﬁned by
unit-speciﬁc policy used to deﬁne immature
skin; 70% alcohol preparation and /or Betadine
preparation; scrub time minimum of 30 s and
a dry time minimum of 30 s but up to 2 min
recommended
o >2 mo or corrected GA or weight as deﬁned by
unit-speciﬁc policy used to deﬁne mature skin;
ChloraPrep or comparable chlorhexidine unitbased product; scrub time minimum suggested 30 s;
dry time minimum suggested 30 s and up to 2 min
o For groin/axilla; a 2-min scrub with minimum of
60 s dry time and up to 2 min recommended
Daily assessment of central line need and utilization
Checklist for ongoing need for access, frequency of line
entry, line complications, and/or mechanical problems
Establish formal reaction team for bedside analysis
when CLABSI is identiﬁed

GA, gestational age; PICC, peripherally inserted central catheter.

and process measure compliance
data monthly.
Monthly CLABSI rates ([CLABSI
events divided by central linedays] × 1000) for each center were
analyzed as time series outcome
variables by using Statistical Process
Control charts (Shewhart u charts).28
Rational subgrouping was used to
study both variation over time and

variation between NICUs and test
groups. Signals, indicating special
cause, were identified by using
standard control chart rules. After
detecting special cause signals that
supported a significant change, the
limits for the u chart were calculated
for both the baseline and study
periods, and signals that indicated
a change in the time series were
identified.
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Power was calculated by using
a historical CLABSI rate from
a sampling of CHND centers.
Preliminary calculations found a
baseline rate of 1.1 per 1000 linedays; however, once data from all
of the participating centers were
available, the actual baseline rate was
later determined to be 1.33 per 1000
line-days. Average monthly line-days
needed for each test group were
estimated to be 1000, yielding an SE
for each test group of 1.05. Thus, the
SE of the difference in factor levels
was 0.742. A baseline and study
period of 6 months would allow
the detection of a change in CLABSI
rate >0.3 (under ideal experimental
conditions). To achieve this power,
a minimum replication of 6000 linedays per test group was required
over the study period. Study-It
software (McGraw-Hill Professional,
New York, NY) was used to estimate
and analyze each of the 4 factors’
effect and their interactions and to
create the appropriate response
plots.22 Main effect terms for each
of the factors in the study were
evaluated. This analytical approach
assumes that the effects of all
factors and interaction pairs can be
evaluated. Correlation analysis with
scatter plots was used to assess for
any association between compliance
and CLABSIs. This methodology does
not involve confidence intervals
or P values but does use statistical
process control charts and repetition
to verify the results.

TABLE 2 Study Factors and Their Deﬁnitions
Factor

Level

HC

Monitoring
Not monitoring
Sterile

TC technique

Deﬁnition

Clean
CVC access
Line removal
assessment

Special
General
Yes
No

Monitor compliance with unit-based HC policy
No compliance monitoring with unit-based HC policy
Deﬁned by unit policy but must have a minimum to include hand
hygiene and sterile gloves and mask with use of sterile
barrier under the CVC
Deﬁned by unit policy but must have a minimum of hand hygiene
and clean gloves with sterile gauze barriers under the CVC
Unit policy in place for limitation of CVC entry
No unit policy in place for CVC entry
Unit policy to assess CVC daily need and utilization
No unit policy to assess CVC daily need and utilization

The factors are outlined with their dichotomous deﬁnition for this project. Centers followed these deﬁnitions for reporting
according to their OT matrix assignment.

TABLE 3 Four Factor OT Design Matrix With 16 Centers
Group

Hub Care

TC

CVC
Access

Line
Removal
Assessment

1

Not
monitoring
Monitoring
Monitoring

Clean

General

No

B

0.624

0.467

−0.157

Sterile
Clean

General
Special

No
No

Special

No

2.343
1.031
1.265
1.230

0.480
0.591
0.844
0.547

−1.860
−0.433

Sterile

C
D
E
F

Clean

General

Yes

H
A
K

1.187
0.944
2.184

1.875
2.166
1.628

0.512

Sterile

General

Yes

I

0.934

2.072

J

3.407

1.510

2
3
4
5

6

7
8

Not
monitoring
Monitoring

Not
monitoring
Not
monitoring
Monitoring

Clean
Sterile

Special
Special

Yes
Yes

Hospital
CLABSI Rates
Change in
ID
CLABSI
Rate
Baseline
Study
Period
Period for Groups

L

3.107

0.926

N
O
P
Q
R

0.226
2.001
0.866
0.485
2.502

0.098
0.9413
0.713
0.470
1.465

1.333

1.076

All
groups

−0.683

0.444

−0.534

−0.548
−0.257

This design matrix shows dichotomous factors with group and hospital assignments. The baseline period was January
2011 through December 2011, and the study period was January 2012 through December 2012. CLABSI rates are deﬁned
per 1000 line-days. Hospital G was removed because of nonadherence to assignment, and hospital M withdrew from the
project.

RESULTS
The collaborative CLABSI rate
decreased from a baseline rate
of 1.333 to 1.076 per 1000 linedays, a 19.28% reduction. During
the baseline period, there was no
special cause signal that indicated
random variation in rates across
the participating sites from January
2011 to August 2011. However, after
8 months, the collaborative CLABSI
rates showed a special cause signal

on the u chart. After this signal, a new
center-line was determined and was
sustained for the remaining 4 months
(Fig 1). A total of 235 990 line-days
(116 987 in the baseline period and
119 003 in the study period) were
analyzed. Three single-center groups
(1, 2, and 4) consistently had <1000
line-days per month; group 6 had 8
months of <1000 line-days and group
7 had 3 months of <1000 line-days;
and groups 3, 5, and 8 had >1000

line-days each month throughout the
study period.
Fourteen of the 17 centers had a
decrease in rates during the study
period (Table 3). Among the 4
infection prevention factors, sterile
TC decreased CLABSI rates by an
average of 0.51. The addition of HC
compliance monitoring produced
the strongest effect (interaction of
sterile TC with HC monitoring), with
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an average decrease in CLABSI rates
of 1.25 per 1000 line-days (Fig 2).
Figure 3 displays the consistency
and variation of the TC change and
HC effects shown in Fig 2. Three of
the 4 test groups using sterile TC
demonstrated a decrease in CLABSI
rates (Table 3, Fig 3). Group 2 (a
single-center group) that performed
both HC monitoring and sterile
TC techniques demonstrated the
greatest decrease. Three of the 4
groups using clean TC (5 centers;
groups 1, 3, and 7) had baseline
CLABSI rates below the collaborative
mean and maintained low rates.
Group 5, comprising 3 centers using
clean TC, had a baseline mean of 1.39
and an increase in CLABSI rates at
the completion of the study.
Most centers reported compliance by
using a combination of self-reporting
or direct observation. There was no
association between compliance and
CLABSI rates. Sixteen centers achieved
>75% compliance, and 12 of these
centers reached >90% compliance.
HC compliance ranged from 92% to
100%, whereas TC technique
compliance ranged from 82% to
100%. The CVC device utilization
ratio did not change over time. Four
teams reporting on the balancing
measure (2 with specific monitoring
for CVC removal and 2 without such
monitoring) showed no change in
need for line replacement. Using the
IHI assessment score25 as a measure of
local team success, 11 of 17 centers
achieved scores ≥3.5 (moderate
achievement), and 6 of 17 achieved
scores ≥4 (significant improvement).

DISCUSSION
The present QI project had 2
objectives: (1) to reduce CLABSI rates
by 15% over 12 months; and (2) to
identify potential best practices for
CLABSI prevention. With regard to
the first objective, all participating
centers had active CLABSI prevention
policies at the onset of the project and
most had CLABSI rates lower than the

TABLE 4 Project Measures and Deﬁnitions
Measure
Outcome

Process

CLABSI rate
Device utilization
ratio
HC
Limitations on CVC
access
Line removal
assessment
Tubing change
compliance
Staff hand hygienea

Balancing

Unintended CVC
replacement

Deﬁnition
(CLABSI events per month/the number of central line–days per
month) × 1000
Total central line–days per month/total patient-days per month
Compliance with HC technique/number of HC encounters monitored.
Minimum of 10 observations per month
Total patients with CVC properly assessed for limitation of entry/total
patients with CVC assessed for limitation of entry. Minimum of 10
observations per month
Compliance with unit policy to assess CVC daily need/the number of
CVC monitored. Minimum of 10 observations per month
Total number of properly performed TC according to unit policy and
in accordance with matrix-assigned technique/total number of TC
monitored. Minimum of 10 observations per month
Total number of properly performed hand hygiene observations /
total number of observations. Minimum of 20 observations per month
Number of lines that were reinserted within 48 h after CVC removal
because they were determined not to be medically needed/total
number of lines

Four of the listed process measures were study factors in accordance with the matrix assignment.
a Hand hygiene was reported as a background variable throughout the study period.

FIGURE 1
SLUG Bug CLABSI rates from extended baseline throughout the study period for 17 participating
centers. The u chart displays a decrease in CLABSI rates, from 1.333 to 1.076 per 1000 line-days.
Statistical Process Control special-cause signaling (8 consecutive points below the mean). There
was no further signaling for the duration of the study period. The overall reduction was 19.28%. LCL,
lower control limit; UCL, upper control limit.

national average. Nevertheless, we
reported a collaborative reduction in
CLABSI rates from baseline by nearly
20% in the first 8 months of the study
period. Second, utilizing OT as a study
design, this collaborative is the first
to be able to identify specific factors
that may further impact NICU CLABSI
reductions.
The literature supports
implementation of evidence-based

guidelines or care bundles to
reduce CLABSI rates across a wide
range of settings.1,29–35 Bizzarro et
al31 reported on their single-site
reduction in NICU CLABSI from 8.4 to
1.28 per 1000 central line-days after
an education initiative that included
CVC management guidelines. In a
large statewide study by Pronovost et
al,1 QI strategies and implementation
of an evidence-based intervention
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reflect a culture of heightened
vigilance for line care.

FIGURE 2
A, Interaction plot between TC and monitoring HC. B, Response plot for TC alone.

FIGURE 3
CLABSI control chart for each OT group. Eight groups (16 centers) showing change in CLABSI rates
from baseline during the study period. Dashed gray lines are clean TC groups; dashed and solid black
lines are sterile TC groups. Group 2, 3, 5, and 8 are HC monitoring. Solid black lines are sterile TC and
HC monitoring. LCL, lower control limit; UCL, upper control limit.

decreased mean adult ICU CLABSI
rates from 7.7 to 1.4. Miller et al35
reported that the main driver for
additional reduction of CLABSI
rates in a PICU compared with an
adult ICU was the daily maintenance
care bundle. As with many of these
studies, we incorporated evidencebased guidelines and literature. We
also enlisted expert opinion and used
the CHND network to benchmark
best practices for prevention of
CLABSIs.
QI collaboratives have variable
results in demonstrating
improvement, cost-effectiveness,
and sustainability.34,36,37 Although
Wirtschafter et al29 reported a
decrease in CLABSI rates in a
statewide QI-based study, they were
unable to indicate which elements
of the intervention were responsible
for rate changes. Through the use

of OT, we were able to evaluate
specific CLABSI reduction practices
over a relatively short period of time
to identify which factors had the
greatest effect.28,38–40 Using OT, we
found that of the 4 factors studied,
sterile TC had an effect in decreasing
CLABSI rates. The combination
of sterile TC with HC compliance
monitoring had the greatest effect.
Our results suggest that if a NICU
implements sterile TC practices,
CLABSI rates should decrease by
0.51 per 1000 line-days. If this
same NICU added HC compliance
monitoring, the impact would then
be larger, lowering rates by 1.25 per
1000 line-days. Sterile TC has not
been considered a primary CLABSI
prevention factor but rather has
been recommended in conjunction
with other interventions in standard
CLABSI prevention bundles.21 We
suspect this combination of practices

There are limitations to the SLUG
Bug project. CLABSI prevention is
complex, and additional practices
(beyond the scope of our project)
may contribute to a low CLABSI rate.
Several centers using clean TC had
low CLABSI rates throughout the
collaborative. These centers may
have established practices, individual
or in combination, that are important
but were not monitored. Lastly, there
was unequal distribution of centers
and central line–days across groups.
Due to this variability, the estimate
of the magnitude of the effect was
not as accurate as initially planned.
However, one of the strengths of OT
is that the analysis is based on group
outcome rather than center outcome
and, with sufficient replication (ie,
central line–days across sites), it
provides the strength to define the
generalizable impact of the study
factors.
Forgoing randomization may be
considered a weakness, resulting in
a biased estimation of factor effects
and unequal line-day distribution.
OT, as an application of planned
experimentation without center
randomization, uses graphical
methods with repeated samples to
identify improvement in real time
over a wide range of conditions.22,23
In addition, we did not capture the
change in practice among centers
as they entered the project. Some
centers maintained their current
central line care while others
instituted a change in practice. It is
through replication in future systems
that the benefits of the OT results will
be confirmed. This analytic approach
to QI is a relatively new concept. We
believe this method strengthens the
project because it represents realworld dynamics and may lead to
greater commitment as local teams
(or centers) focus on areas of specific
importance to their systems. As such,
these results are more generalizable
to clinical practice.
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There are challenges in QI
implementation across participating
centers that may have competing
commitments for time and
personnel.30 Despite the initial
assignments, 1 center was moved
to a different group to reconcile
the clinical practice with the group
factor assignment; 1 center never
submitted data and was removed
from all analytics; and the data from
1 center were retained for overall
analysis but removed from the OT
analysis because their practice did
not coincide with the matrix group
assignment.
This cohort included a complex
patient population across
institutions. The CLABSI Clinical
Practice Recommendation is
generalizable to other settings in
which prolonged CVC use is medically
necessary. Replication of these
findings is important to
confirm validity of the results.22
Ongoing analysis will evaluate
sustainability of these results. In
addition, centers that transition
to sterile TC can be followed to
validate the impact of this practice.
Decreasing the CLABSI rate offers
benefits to patients, hospitals, and
society. A decrease in the CLABSI rate
by nearly 20% from a baseline rate
of 1.333 would prevent ∼35 CLABSIs
and save as many as 7 lives.41 Based
on published estimates of up to
$69 000 attributable-cost per CLABSI,
we could expect a cost-saving of up to
$2.4 million.6–11

CONCLUSIONS
The CHND CIQI national project,
SLUG Bug, demonstrated a decrease
in CLABSI rates. OT methods allowed
learning from practice variation
across centers. This approach to
future collaborative QI projects is
feasible and effective. The study
framework accommodated sitespecific differences and identified
practices that affect outcome. Our
results support strong consideration

for the use of sterile TC in
conjunction with HC compliance
monitoring to further reduce NICU
rates of CLABSI.
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APPENDIX
CHNC CIQI Central Line Care Clinical
Practice Recommendations
The purpose of this project was to
provide potentially better practices
recommendations for neonatal

Downloaded from www.aappublications.org/news by guest on October 10, 2018
PEDIATRICS Volume 137, number 1, January 2016

7

health care professionals for the
care and maintenance of central
lines to prevent CLABSIs in infants
in the NICU. Prevention of CLABSIs
in the NICU will result in a decrease
in both the morbidity and mortality
associated with medical conditions
that require care in the NICU, as well
as an associated decrease in health
care costs.

Hand Hygiene
The definition of hand hygiene (for
staff and families) includes hand
washing or use of hand sanitizer
immediately before and after patient
contact.42–52

Report results
Develop monthly reports to share with
staff
Consider monitoring hand
hygiene compliance of families and
visitors
Consider sharing reports of both staff
and family/visitor hand hygiene with
families/visitors

Attachment A (samples of reporting
tools for Hand Hygiene)
CENTRAL LINE INSERTION BUNDLE

When decontaminating hands with
an alcohol-based hand rub, apply
product to the palm of 1 hand
and rub hands together, covering
all surfaces of hands and fingers,
until hands are dry. Follow the
manufacturer’s recommendations
regarding the volume of product to
use.

CVC: A vascular infusion device that
terminates at or close to the heart
or in 1 of the great vessels.51,52
The following are considered great
vessels for the purpose of reporting
central line infections and counting
central line–days in the National
Healthcare Safety Network system:
aorta, pulmonary artery, superior
vena cava, inferior vena cava,
brachiocephalic veins, internal
jugular veins, subclavian veins,
umbilical vessels, external iliac veins,
and common femoral veins.

Soap and Water

Central Line Insertion

Hand Hygiene Technique
Alcohol Based

When washing hands with soap
and water, wet hands first with
water, apply an amount of product
recommended by the manufacturer
to hands, and rub hands together
vigorously for at least 15 seconds,
covering all surfaces of the hands
and fingers. Rinse hands with water
and dry thoroughly with a disposable
towel. Use towel to turn off the
faucet.

Hand Hygiene Compliance
Direct observation of staff to include
physicians, nurses, and all ancillary
personnel. Minimum 20 observations
per month
Reliable observers with consistent
education and training; share results
with staff

in patient “space” during line
insertion must wear mask and
head cover

Site Preparation
<2 months or corrected gestational
age (GA) or weight as defined by
unit-specific policy used to define
immature skin55
70% Alcohol preparation and/or
Betadine preparation
Scrub time: suggest 30-second
minimum
Dry time: suggest 30-second
minimum (up to 2 minutes)
≥2 months or corrected-GA or weight
as defined by unit-specific policy
used to define mature skin
ChloraPrep or comparable
chlorhexidine unit-based
product
Scrub time: suggest 30-second
minimum
Dry time: suggest 30-second
minimum (up to 2 minutes)
Groin (not a preferred site for
central access)
Suggest 2-minute scrub with
minimum of 60-second dry
time (up to 2 minutes)

Dedicated teams to place lines
might be beneficial for promoting
education and consistency of the
insertion process. Team members
may include trained registered
nurses, neonatologists, neonatal
nurse practitioners, surgeons,
and interventional radiology
physicians.48,53,54

Site Dressing

Hand Hygiene Before Procedure/Sterile
Barrier Precautions

Checklist for compliance with
insertion on each line placed

Cover patient head to toe (head may
be uncovered) with appropriate
monitoring devices

Attachment B (samples of reporting
tools for line insertion)

All individuals actively involved in
line placement must wear mask,
head cover, sterile gown, and
sterile gloves
All individuals not actively involved
in line placement but present

Document CVC tip by radiograph and
in chart.

Apply sterile dressing per
manufacturer specifications

Central Line Insertion Compliance

CENTRAL LINE USE AND MAINTENANCE
Maintenance bundle compliance
to include dressing change, chart
documentation, daily assessment
need, medication delivery, TC, and
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blood draw components of policy/
procedure.48,51,54–60

Central Line Dressing Change
Dressing Change Per NICU Protocol

Site Preparation

TC

<2 months OR corrected-GA or
weight as defined by unit-specific
policy used to define immature
skin

Hand hygiene before procedure

Broviac: weekly and as-needed if
dressing becomes wet, soiled, or
nonocclusive

70% Alcohol preparation and/or
Betadine preparation

Peripherally inserted central
catheter (central and midline):
weekly and as-needed if
dressing becomes wet, soiled, or
nonocclusive

Dry time: 30-second minimum (up
to 2 minutes recommended)

Subclavian/jugular/femoral:
change weekly and as-needed if
dressing becomes wet, soiled, or
nonocclusive
No occlusive dressing for umbilical
artery catheter and umbilical
venous catheter
Some centers use 2 staff members for
dressing changes
Position line hub and catheter away
from dirty areas such as ostomy,
diaper, or exposed viscera

Hand Hygiene Before Procedure
Current dressing may be removed
with clean gloves and hand hygiene
performed after removal of
gloves

Barrier Precautions for Dressing
Change
Dressing changes require sterile
technique. All individuals actively
involved in dressing change must
wear mask and sterile gloves
Some centers add clean gown/head
covering
Some centers use sterile barrier to
cover patient head to toe

Site Dressing
Apply sterile dressing per
manufacturer specifications
Track date/time of dressing change,
insertion, and removal

Scrub time: 30-second minimum

≥2 months OR corrected-GA or
weight as defined by unit-specific
policy used to define mature
skin
ChloraPrep or comparable
chlorhexidine unit-based
product
Scrub time: suggest 30-second
minimum

Sterile versus clean technique
(scant literature to support either
protocol; divided practices exist
among participating centers)
Options include:
Sterile technique: minimum should
include sterile gloves and mask
with use of sterile barrier under
the CVC
Clean technique: minimum
should include clean gloves with
sterile gauze barriers under the
CVC
Scrub the hub53,61
70% Alcohol preparation or
ChloraPrep as per NICU
protocol

Dry time: suggest 30-second
minimum (up to 2 minutes)

Scrub time: 15-second minimum
(up to 60 seconds)

Groin/axilla

Dry time: until dry

2-minute scrub with minimum
of 60-second dry time (up to 2
minutes recommended)

Multiple medication/simultaneous
line entry
Repeat HC per NICU protocol

Central Line HC/Blood Draws/
Medication Infusion
Deﬁnition of Hub/Entry Point
Any time there is an opening or
access of the CVC at the hub/cap/
manifold for a break in the system.

Review Unit-Based Protocols for Central
Line Set-up
Minimize/standardize number of
entry ports
Consider line set-ups to avoid entry
ports remaining in bed

Blood Draws/Medication Delivery/
Fluid and TC
Blood Draws/Medication Delivery/
Fluid Change
Hand hygiene before procedure
Limit line entry access (medications
and blood draws)
Follow HC (discussed later)

TC schedule
Hyperalimentation tubing: 24 to
72 hours (up to 96 hours may be
safe)
Lipids: 24 hours
Crystalloids: 24 to 96 hours (up to
7 days may be safe)

Monitor Compliance for
Maintenance Bundle Compliance
Attachment C (samples of selfreporting tools for central line use
and maintenance)
Minimum of 10 monthly selfreport monitors (each self-report
includes a 12-hour shift) for
maintenance bundle compliance
to include dressing change,
medication delivery, TC, and
blood draw components of policy/
procedure
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Minimum 10 monthly observations
Report results

Monitor Compliance for Daily Need
for CVC
ABBREVIATIONS

Develop reports to share with staff

REMOVAL
Daily CVC Need and Assessment
Documentation
Daily assessment of central line need
and utilization57–59
Things to consider
→Mechanical issues in the past
24 hours (line clotted/tissue
plasminogen activator used, line
to be repaired)
→Frequency of line entry

Attachment D (samples of selfreporting tools for central line
removal)
Checklist for ongoing need for
access, frequency of line entry, line
complications, and/or mechanical
problems
Report results to staff

CVC CLABSI Review Form
Attachment D (samples of selfreporting tools for CLABSI review)
Root cause analysis49,50
Formal reaction team for bedside
analysis suggested when CLABSI is
identified

CHND: Children’s Hospitals
Neonatal Database
CIQI: Collaborative Initiatives for
Quality Improvement
CLABSI: central line–associated
bloodstream infection
CVC: central venous catheter
HAI: health care–associated
infection
HC: hub care
IHI: Institute for Healthcare
Improvement
OT: orchestrated testing
QI: quality improvement
SLUG Bug: Standardizing Line
Care Under Guideline
Recommendations
TC: tubing change
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